Two Sigma Investments LP Sells 294,568 Shares of Cardinal Health, Inc. (NYSE:CAH)

Two Sigma Investments LP cut its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 23.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 943,519 shares of the company's stock after selling 294,568 shares during the quarter. Two Sigma Investments LP owned approximately 0.39% of Cardinal Health worth $111,590,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Rothschild Investment LLC increased its position in shares of Cardinal Health by 10.1% during the 4th quarter. Rothschild Investment LLC now owns 858 shares of the company's stock valued at $101,000 after purchasing an additional 79 shares during the last quarter. Private Trust Co. NA lifted its stake in Cardinal Health by 11.0% in the fourth quarter. Private Trust Co. NA now owns 930 shares of the company's stock valued at $110,000 after purchasing an additional 92 shares during the last quarter. Checchi Capital Advisers LLC lifted its stake in Cardinal Health by 2.7% in the fourth quarter. Checchi Capital Advisers LLC now owns 3,479 shares of the company's stock valued at $411,000 after purchasing an additional 93 shares during the last quarter. TIAA Trust National Association lifted its stake in Cardinal Health by 4.5% in the fourth quarter. TIAA Trust National Association now owns 2,183 shares of the company's stock valued at $258,000 after purchasing an additional 94 shares during the last quarter. Finally, MWA Asset Management lifted its stake in Cardinal Health by 2.9% in the fourth quarter. MWA Asset Management now owns 3,324 shares of the company's stock valued at $393,000 after purchasing an additional 95 shares during the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Trading Up 0.2%

Shares of CAH traded up $0.24 during mid-day trading on Friday, reaching $152.73. 1,856,640 shares of the stock traded hands, compared to its average volume of 2,227,745. The firm has a fifty day moving average price of $139.58 and a 200 day moving average price of $129.09. The company has a market cap of $36.45 billion, a price-to-earnings ratio of 28.49, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $156.44.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Thursday, May 1st. The company reported $2.35 earnings per share for the quarter, beating analysts' consensus estimates of $2.15 by $0.20. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. The business had revenue of $54.88 billion for the quarter, compared to the consensus estimate of $55.33 billion. During the same period last year, the firm posted $2.08 earnings per share. Cardinal Health's quarterly revenue was up .0% on a year-over-year basis. On average, sell-side analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be given a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a yield of 1.34%. The ex-dividend date of this dividend is Tuesday, July 1st. This is a boost from Cardinal Health's previous quarterly dividend of $0.51. Cardinal Health's dividend payout ratio (DPR) is presently 31.83%.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. Jefferies Financial Group upgraded Cardinal Health from a "hold" rating to a "buy" rating and upped their price objective for the company from $140.00 to $150.00 in a research note on Wednesday, February 5th. Mizuho lifted their target price on shares of Cardinal Health from $142.00 to $150.00 and gave the stock an "outperform" rating in a research note on Monday, March 31st. Wall Street Zen upgraded shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a research note on Monday, May 5th. UBS Group lifted their target price on shares of Cardinal Health from $150.00 to $160.00 and gave the stock a "buy" rating in a research note on Tuesday, April 29th. Finally, Robert W. Baird lifted their target price on shares of Cardinal Health from $156.00 to $170.00 and gave the stock an "outperform" rating in a research note on Friday, May 2nd. Four analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $146.43.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.